NutriBand (NTRB) Interest Coverage Ratio (2017 - 2026)
NutriBand (NTRB) posted Interest Coverage Ratio of 0.24 for Q2 2026, down 100.38% sequentially from 64.0 in Q1 2026, and up 99.6% YoY from 0.12 in Q2 2025.
NutriBand (NTRB) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
NutriBand has reported Interest Coverage Ratio for 10 years, with the latest figure at 0.24 in Q2 2026.
- Quarterly Interest Coverage Ratio rose 99.6% year-over-year to 0.24 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 1.6 (up 99.61% YoY) and the FY2026 annual result came in at 0.87, up 32.0% from the prior year.
- Interest Coverage Ratio declined to 0.24 in Q2 2026 per NTRB's latest filing, from 64.0 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 64.0 in Q1 2026 and troughed at 233.52 in Q3 2022.
- A 5-year average of 21.6 and a median of 5.4 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2026: Interest Coverage Ratio plunged 1886.27% in 2022, then surged 9335.99% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 9.77 in 2022, then slumped by 235.31% to 32.77 in 2023, then surged by 98.95% to 0.34 in 2024, then plunged by 228.44% to 1.13 in 2025, then jumped by 78.69% to 0.24 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.24, 64.0, and 1.13 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | -250.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.24 |
| Jan 31, 2026 | 64.00 |
| Oct 31, 2025 | -1.13 |
| Jul 31, 2025 | -0.42 |
| Apr 30, 2025 | -59.90 |
| Jan 31, 2025 | -0.69 |
| Oct 31, 2024 | -0.34 |
| Jul 31, 2024 | -4.73 |
| Apr 30, 2024 | -15.69 |
| Jan 31, 2024 | -56.27 |
| Oct 31, 2023 | -32.77 |
| Jul 31, 2023 | -7.29 |
| Apr 30, 2023 | -4.74 |
| Jan 31, 2023 | 15.32 |
| Oct 31, 2022 | -9.77 |
| Jul 31, 2022 | -233.52 |
| Apr 30, 2022 | -6.06 |
| Jan 31, 2022 | -34.64 |
| Oct 31, 2021 | -8.98 |
| Jul 31, 2021 | -11.76 |